Sign in to view content

Characteristics and the Need for Supplementation Following 0.19mg Fluocinolone Acetonide (FAc) in Diabetic Macular Edema (DME) Patients

Victor Hugo Gonzalez, MD

Video
Published 2021

Related

Episode 204: Journal Club Featuring AMD Cost Analysis, DME Real-World Trends, PVDs and Retinal Breaks
Jayanth Sridhar, MD
Member Podcasts
2019
Suprachoroidal Triamcinolone Acetonide with and without Intravitreal Aflibercept for Diabetic Macular Edema: Results of the 6-Month Prospective, Phase 1/2 Hulk Study
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2017
Episode 8: DAVE Trial: Targeted Retinal Photocoagulation for DME with Dr. David Brown
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018

Category: Diabetic Retinopathy

See more